🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is for people who have recurrent or metastatic head and...
Status
Withdrawn
Location
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute
Start Date
2026-01
Trial ID
NCT07216833
Treatments Being Tested
This study is being done because both 5-azacytidine and nivolumab can influ...
Status
Recruiting
Location
Yale University
Start Date
2023-03-23
Trial ID
NCT05317000
Treatments Being Tested
The goal of this clinical research study is to learn if lirilumab and Opdiv...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2016-03-21
Trial ID
NCT02599649
Treatments Being Tested
There is evidence of involvement of checkpoint pathways, including PD-1, in...
Status
Terminated
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2017-05-25
Trial ID
NCT03259516
This phase II trial studies the side effects of nivolumab and/or ipilimumab...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2015-09-08
Trial ID
NCT02530463
Treatments Being Tested
This trial studies the side effects of nivolumab in combination with decita...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2020-03-11
Trial ID
NCT04277442
Treatments Being Tested
This is a Phase I study to determine the optimal biological dose (OBD) of 5...
Status
Recruiting
Location
University of Iowa Health Care
Start Date
2026-02-11
Trial ID
NCT07404332
Treatments Being Tested
This is a phase I/II Study of Nivolumab in Combination with 5-azacytidine i...
Status
Unknown
Location
Children's Hospital of Los Angeles
Start Date
2019-11-29
Trial ID
NCT03825367
Treatments Being Tested
The clinical trial will test the safety and tolerability of a combination t...
Status
Unknown
Location
University Hospital, LMU Munich
Start Date
2021-05-05
Trial ID
NCT04913922
Treatments Being Tested
This will be a phase II, open-label, non-randomized study with a safety lea...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-04-07
Trial ID
NCT02397720
Treatments Being Tested